2. Search Result
Search Result
Results for "

RUNX

" in MedChemExpress (MCE) Product Catalog:

38

Inhibitors & Agonists

1

Biochemical Assay Reagents

12

Natural
Products

8

Antibodies

11

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-174367
    RUNX1/ETO-IN-1

    		RUNX Apoptosis Cancer
    RUNX1/ETO-IN-1 is a RUNX1-ETO oncogenic fusion protein inhibitor that specifically targets the NHR2 oligomerization domain. RUNX1/ETO-IN-1 directly interacts with the NHR2 (KD,app = 39 μM). RUNX1/ETO-IN-1 exhibits anti-leukemic activity by inducing apoptosis and promoting differentiation in RUNX1/ETO-translocated AML cells. RUNX1/ETO-IN-1 remains essentially uncharged at physiological pH, demonstrating superior membrane permeability.
    RUNX1/ETO-IN-1
  • HY-151411
    RUNX1/ETO tetramerization-IN-1

    		RUNX Cancer
    RUNX1/ETO tetramerization-IN-1 is a small-molecule inhibitor of RUNX1/ETO tetramerization, exhibits anti-leukemic effect. RUNX1/ETO tetramerization-IN-1 specifically targets to NHR2 of RUNX1/ETO (EC50=0.25 μM), restores gene expression down-regulated by RUNX1/ETO. RUNX1/ETO tetramerization-IN-1 inhibits the proliferation of RUNX1/ETO-depending SKNO-1 cells, and reduces the RUNX1/ETO-related tumor growth in a mouse model .
    RUNX1/ETO tetramerization-IN-1
  • HY-155991
    RUNX-IN-2

    		Apoptosis Cancer
    RUNX-IN-2 (Compound Conjugate 3) covalently binds to the RUNX-binding sequences, and inhibits the binding of RUNX proteins to their target sites. RUNX-IN-2 induces the p53-dependent apoptosis and inhibits cancer cell growth. RUNX-IN-2 inhibits tumor growth in PANC-1 xenograft mice. RUNX-IN-2 has high alkylation efficiency and specificity .
    RUNX-IN-2
  • HY-124137
    Runx1-CBFβ interaction inhibitor 1

    		RUNX Cancer
    Runx1-CBFβ interaction inhibitor 1 is an allosteric inhibitior of Runt domain-CBFb interaction (IC50=3.2 μM) .
    Runx1-CBFβ interaction inhibitor 1
  • HY-RS16650
    Runx1 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Cancer

    Runx1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Runx1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Runx1 Mouse Pre-designed siRNA Set A
    Runx1 Mouse Pre-designed siRNA Set A
  • HY-RS26603
    Runx3 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Runx3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Runx3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Runx3 Rat Pre-designed siRNA Set A
    Runx3 Rat Pre-designed siRNA Set A
  • HY-RS12352
    RUNX3 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    RUNX3 Human Pre-designed siRNA Set A contains three designed siRNAs for RUNX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    RUNX3 Human Pre-designed siRNA Set A
    RUNX3 Human Pre-designed siRNA Set A
  • HY-RS16864
    Runx2 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Runx2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Runx2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Runx2 Mouse Pre-designed siRNA Set A
    Runx2 Mouse Pre-designed siRNA Set A
  • HY-RS12349
    RUNX1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    RUNX1 Human Pre-designed siRNA Set A contains three designed siRNAs for RUNX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    RUNX1 Human Pre-designed siRNA Set A
    RUNX1 Human Pre-designed siRNA Set A
  • HY-RS23305
    Runx2 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Runx2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Runx2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Runx2 Rat Pre-designed siRNA Set A
    Runx2 Rat Pre-designed siRNA Set A
  • HY-RS23085
    Runx1 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Runx1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Runx1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Runx1 Rat Pre-designed siRNA Set A
    Runx1 Rat Pre-designed siRNA Set A
  • HY-RS12351
    RUNX2 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    RUNX2 Human Pre-designed siRNA Set A contains three designed siRNAs for RUNX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    RUNX2 Human Pre-designed siRNA Set A
    RUNX2 Human Pre-designed siRNA Set A
  • HY-RS20100
    Runx3 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Runx3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Runx3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Runx3 Mouse Pre-designed siRNA Set A
    Runx3 Mouse Pre-designed siRNA Set A
  • HY-RS12350
    RUNX1T1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    RUNX1T1 Human Pre-designed siRNA Set A contains three designed siRNAs for RUNX1T1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    RUNX1T1 Human Pre-designed siRNA Set A
    RUNX1T1 Human Pre-designed siRNA Set A
  • HY-174541
    Human RUNX1 mRNA

    		mRNA Cancer
    Human RUNX1 mRNA encodes the human RUNX family transcription factor 1 (RUNX1) protein, the alpha subunit of Core binding factor (CBF). RUNX1 can forms the heterodimeri CBF with CBFB and is thought to be involved in the development of normal hematopoiesis.
    Human RUNX1 mRNA
  • HY-138617
    AI-10-47
    1 Publications Verification

    		 RUNX Cancer
    AI-10-47 is a small molecule inhibitor of CBFβ-RUNX binding, with an IC50 of 3.2 μM .
    AI-10-47
  • HY-108470
    Ro5-3335
    5+ Cited Publications

    		 RUNX Cancer
    Ro5-3335, a benzodiazepine, acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation .
    Ro5-3335
  • HY-107999
    CADD522
    4 Publications Verification

    		 Reactive Oxygen Species (ROS) Cancer
    CADD522 is a RUNX2-DNA binding inhibitor (downregulates RUNX2-mediated transcription of downstream target genes), with an IC50 of 10 nM. CADD522 inhibits primary tumor growth and experimental metastasis of tumor cells in the lungs of immune-compromised mice. CADD522 can be used in study of cancer .
    CADD522
  • HY-118365
    NSC 140873

    		RUNX Infection Cancer
    NSC 140873 is an inhibitor of the RUNX1-CBFβ interaction. NSC 140873 can be used for research of viral infection and leukemia. NSC 140873 has an unstable structure and can be converted spontaneously in solution to a benzodiazepine (Ro5-3335) .
    NSC 140873
  • HY-122657
    AI-10-104

    		RUNX Cancer
    AI-10-104 is an inhibitor for runt-related transcription factor (RUNX), which enhances the cytotoxicity in myeloma cells .
    AI-10-104
  • HY-127090
    Muramyl dipeptide
    5+ Cited Publications

    MDP

    		 p38 MAPK NOD-like Receptor (NLR) Inflammation/Immunology Cancer
    Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. Muramyl dipeptide is an inducer of bone formation through induction of Runx2. Muramyl dipeptide directly enhances osteoblast differentiation by up-regulating Runx2 gene expression through MAPK pathways. Muramyl dipeptide is a NLRP1 agonist .
    Muramyl dipeptide
  • HY-W014410
    Mucic acid

    		Others Endocrinology
    Mucic acid (Galactaric acid) is a building block for polymers. Mucic acid stimulates Runx2 mRNA expression. Mucic acid can be used in polymer synthesis and bone tissue engineering research .
    Mucic acid
  • HY-125966
    AI-4-57

    		RUNX Cancer
    AI-4-57 is an allosteric inhibitor for CBFβ SMMHC-RUNX1 (core binding factor β and the smooth-muscle myosin heavy chain) interaction with an IC50 of 22 μM .
    AI-4-57
  • HY-W014410R
    Mucic acid (Standard)

    		Reference Standards Biochemical Assay Reagents RUNX Endocrinology
    Mucic acid (Standard) is the analytical standard of Mucic acid (HY-W014410). This product is intended for research and analytical applications. Mucic acid (Galactaric acid) is a building block for polymers. Mucic acid stimulates Runx2 mRNA expression. Mucic acid can be used in polymer synthesis and bone tissue engineering research .
    Mucic acid (Standard)
  • HY-16786
    AI-10-49

    		RUNX Inflammation/Immunology Cancer
    AI-10-49 is an inhibitor of leukemic oncoprotein CBFβ-SMHHC. AI-10-49 inhibits the binding of CBFβ-SMMHCto the RUNX1 Runt domain with IC50 value of 0.26 μM. AI-10-49 can be used for the research of leukemia .
    AI-10-49
  • HY-19149
    Ro24-7429

    		HIV Apoptosis Infection Inflammation/Immunology Cancer
    Ro24-7429 is a potent and orally active HIV-1 transactivator protein Tat antagonist. Ro24-7429 is also a runt-related transcription factor 1 (RUNX1) inhibitor. Ro24-7429 has anti-HIV, antifibrotic and anti-inflammatory effects .
    Ro24-7429
  • HY-N14021
    Petasites japonicus extract

    		DNA/RNA Synthesis Neurological Disease Inflammation/Immunology Cancer
    Petasites japonicus extract is the extract from Petasites japonicus with antioxidant, anti-inflammatory, anti-obesity, neuroprotective and anti-cancer effects. Petasites japonicus extract promotes osteoblast differentiation via up-regulation of Runx2 and Osterix in MC3T3-E1 cells .
    Petasites japonicus extract
  • HY-N2375
    L-Quebrachitol

    		Wnt β-catenin p38 MAPK Metabolic Disease
    L-Quebrachitol is a methoxy analog of inositol that can be isolated from plants. L-Quebrachitol has free-radical scavenging, gastroprotection, anti-platelet aggregation and anti-diabetic activity. L-Quebrachitol promotes osteoblastogenesis by uppregulation of BMP-2, runt-related transcription factor-2 (Runx2), MAPK (ERK, JNK, p38α), and Wnt/β-catenin signaling pathway .
    L-Quebrachitol
  • HY-N2375R
    L-Quebrachitol (Standard)

    		Wnt β-catenin p38 MAPK Metabolic Disease
    L-Quebrachitol is a methoxy analog of inositol that can be isolated from plants. L-Quebrachitol has free-radical scavenging, gastroprotection, anti-platelet aggregation and anti-diabetic activity. L-Quebrachitol promotes osteoblastogenesis by uppregulation of BMP-2, runt-related transcription factor-2 (Runx2), MAPK (ERK, JNK, p38α), and Wnt/β-catenin signaling pathway .
    L-Quebrachitol (Standard)
  • HY-103701
    L-Ascorbic acid 2-phosphate
    4 Publications Verification

    2-Phospho-L-ascorbic acid; LAA2P

    		 Phosphatase Reactive Oxygen Species (ROS) Endogenous Metabolite Metabolic Disease
    L-ascorbic acid 2-phosphate (2-Phospho-L-ascorbic acid) is a long-acting vitamin C derivative that can stimulate collagen formation and expression . L-ascorbic acid 2-phosphate (2-Phospho-L-ascorbic acid) can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-ascorbic acid 2-phosphate increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation .
    L-Ascorbic acid 2-phosphate
  • HY-103701B
    L-Ascorbic acid 2-phosphate magnesium hydrate
    2 Publications Verification

    2-Phospho-L-ascorbic acid magnesium hydrate; LAA2P magnesium hydrate

    		 Phosphatase Reactive Oxygen Species (ROS) Endogenous Metabolite Metabolic Disease
    L-ascorbic acid 2-phosphate (2-Phospho-L-ascorbic acid) magnesium hydrate is a long-acting vitamin C derivative that can stimulate collagen formation and expression. L-ascorbic acid 2-phosphate magnesium hydrate can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-ascorbic acid 2-phosphate magnesium hydrate increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation .
    L-Ascorbic acid 2-phosphate magnesium hydrate
  • HY-107837
    L-Ascorbic acid 2-phosphate trisodium
    4 Publications Verification

    2-Phospho-L-ascorbic acid trisodium

    		 Phosphatase Reactive Oxygen Species (ROS) Endogenous Metabolite Metabolic Disease
    L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) is a long-acting vitamin C derivative that can stimulate collagen formation and expression . L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation .
    L-Ascorbic acid 2-phosphate trisodium
  • HY-103701A
    L-Ascorbic acid 2-phosphate magnesium
    4 Publications Verification

    2-Phospho-L-ascorbic acid magnesium; LAA2P magnesium

    		 Phosphatase Reactive Oxygen Species (ROS) Endogenous Metabolite Metabolic Disease
    L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) is a long-acting vitamin C derivative that can stimulate collagen formation and expression . L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation .
    L-Ascorbic acid 2-phosphate magnesium
  • HY-N0946
    (-)-Pinoresinol 4-O-glucoside

    (-)-Pinoresinol 4-O-β-D-glucopyranoside

    		 Glycosidase Metabolic Disease
    (-)-Pinoresinol 4-O-glucoside ((-)-Pinoresinol 4-O-β-D-glucopyranoside) is a potent and orally active α-glucosidase inhibitor with an IC50 value of 48.13 µM. (-)-Pinoresinol 4-O-glucoside increases cell migration and early differentiation of pre-osteoblasts. (-)-Pinoresinol 4-O-glucoside increases protein level of BMP2, p-Smad1/5/8, RUNX2. (-)-Pinoresinol 4-O-glucoside attenuates oxidative stress, hyperglycemia and hepatic toxicity. (-)-Pinoresinol 4-O-glucoside has the potential for the research of osteoporosis and periodontal disease .
    (-)-Pinoresinol 4-O-glucoside
  • HY-16268A
    Kartogenin sodium
    Maximum Cited Publications
    26 Publications Verification

    KGN sodium

    		 TGF-beta/Smad Inflammation/Immunology
    Kartogenin (KGN) sodium is an inducer of chondrogenic tissue formation (EC50: 100 nM). Kartogenin sodium induces chondrogenesis by binding to fibrin A, disrupting its interaction with the transcription factor core binding factor beta subunit (CBFβ), and by modulating the CBFβ-RUNX1 transcriptional program. Kartogenin sodium also promotes tendon-bone junction (TBJ) wound healing by stimulating collagen synthesis. Kartogenin sodium is widely used in cell-free therapy in the field of regeneration for cartilage regeneration and protection, tendon-bone healing, wound healing and limb development. Kartogenin sodium promotes cartilage repair, coordinates limb development, and is also used in osteoarthritis (OA) research .
    Kartogenin sodium
  • HY-16268
    Kartogenin
    Maximum Cited Publications
    26 Publications Verification

    KGN

    		 TGF-beta/Smad Inflammation/Immunology
    Kartogenin (KGN) is an inducer of chondrogenic tissue formation (EC50: 100 nM). Kartogenin induces chondrogenesis by binding to fibrin A, disrupting its interaction with the transcription factor core binding factor beta subunit (CBFβ), and by modulating the CBFβ-RUNX1 transcriptional program. Kartogenin also promotes tendon-bone junction (TBJ) wound healing by stimulating collagen synthesis. Kartogenin is widely used in cell-free therapy in the field of regeneration for cartilage regeneration and protection, tendon-bone healing, wound healing and limb development. Kartogenin promotes cartilage repair, coordinates limb development, and is also used in osteoarthritis (OA) research .
    Kartogenin
  • HY-103701AR
    L-Ascorbic acid 2-phosphate magnesium (Standard)

    2-Phospho-L-ascorbic acid magnesium (Standard); LAA2P magnesium (Standard)

    		 Reference Standards Phosphatase Reactive Oxygen Species (ROS) Endogenous Metabolite Metabolic Disease
    L-Ascorbic acid 2-phosphate (magnesium) (Standard) is the analytical standard of L-Ascorbic acid 2-phosphate (magnesium). This product is intended for research and analytical applications. L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) is a?long-acting?vitamin?C?derivative?that can stimulate collagen formation and expression . L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-Ascorbic acid 2-phosphate magnesium (2-Phospho-L-ascorbic acid magnesium) increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation .
    L-Ascorbic acid 2-phosphate magnesium (Standard)
  • HY-107837R
    L-Ascorbic acid 2-phosphate trisodium (Standard)

    2-Phospho-L-ascorbic acid trisodium (Standard)

    		 Reference Standards Phosphatase Reactive Oxygen Species (ROS) Endogenous Metabolite Metabolic Disease
    L-Ascorbic acid 2-phosphate (trisodium) (Standard) is the analytical standard of L-Ascorbic acid 2-phosphate (trisodium). This product is intended for research and analytical applications. L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) is a long-acting vitamin C derivative that can stimulate collagen formation and expression[1]. L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation[2][3].
    L-Ascorbic acid 2-phosphate trisodium (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: